InvestorsHub Logo
Followers 0
Posts 1
Boards Moderated 0
Alias Born 12/10/2014

Re: None

Wednesday, 12/10/2014 12:09:22 PM

Wednesday, December 10, 2014 12:09:22 PM

Post# of 813
CLVSTo near deaths on cancer drug. Does anyone have any news as to what is going to happen on co-1686 rociletinib. There is news that two patients coded and went vtach with qt syndrome after receiving rociletinib. One was at Stanford, the other in East Bay. This just haened. Will this have a big affect on the stock outlook?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.